podophyllin and diphenylcyclopropenone

podophyllin has been researched along with diphenylcyclopropenone* in 1 studies

Trials

1 trial(s) available for podophyllin and diphenylcyclopropenone

ArticleYear
Effectiveness and safety of topical application of diphenylcyclopropenone versus podophyllin in treatment of genital warts.
    International journal of STD & AIDS, 2023, Volume: 34, Issue:9

    Many therapeutic modalities are available for treating genital warts; however, the effectiveness of both diphenylcyclopropenone and podophyllin is still controversial.. To evaluate the effectiveness and safety of diphenylcyclopropenone and podophyllin in treating genital warts.. This study included 57 patients, divided randomly into two groups. Group (A): diphenylcyclopropenone (. Higher clearance was achieved in group A, with 19 of 29 (65.5%) patients, than in group B, with 9 of 28 (32.1%) (. Diphenylcyclopropenone shows a higher success rate than podophyllin in treating genital warts and a lower recurrence rate.

    Topics: Condylomata Acuminata; Cyclopropanes; Humans; Podophyllin; Warts

2023